Bringing a custom medical product to market is a structured, multi-phase process that balances innovation with rigorous safety and regulatory requirements. Understanding each stage helps clients plan timelines, allocate resources, and set realistic expectations for commercialization.
The process begins with translating a clinical need into a product concept. Feasibility studies evaluate materials, manufacturing methods, and initial cost structures. Early collaboration between your team and our engineers identifies potential design challenges before they become expensive problems.
Following FDA design control requirements (21 CFR 820.30), the development phase produces design inputs, outputs, reviews, verification tests, and validation protocols. Human factors engineering and risk management (ISO 14971) are integrated throughout.
Design transfer translates validated design specifications into controlled manufacturing documents—drawings, BOMs, process instructions, and inspection criteria—ensuring the product can be produced consistently at scale.
Process validation (IQ/OQ/PQ), analytical method validation, and sterilization validation confirm that manufacturing processes reliably produce conforming products every time.
With validation complete, regulatory submissions (510(k), De Novo, PMA, CE Technical File) are prepared and submitted. Post-clearance, commercial production ramps up under the full quality system.